WANY
IDXX icon

Wealthspire Advisors (New York)’s Idexx Laboratories IDXX Stock Holding History

Wealthspire Advisors (New York)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Buy
4,941
+1,545
+45% +$867K 0.01% 373
2026
Q1 		$1.91M Sell
3,396
-1,465
-30% -$939K 0.02% 296
2025
Q4 		$3.29M Buy
4,861
+546
+13% +$372K 0.03% 215
2025
Q3 		$2.76M Buy
4,315
+211
+5% +$128K 0.01% 231
2025
Q2 		$2.2M Buy
4,104
+46
+1% +$22K 0.01% 266
2025
Q1 		$1.7M Buy
4,058
+79
+2% +$34.3K 0.01% 297
2024
Q4 		$1.65M Sell
3,979
-1,358
-25% -$596K 0.02% 275
2024
Q3 		$2.7M Sell
5,337
-25
-0.5% -$12.1K 0.03% 206
2024
Q2 		$2.61M Buy
5,362
+2,930
+120% +$1.47M 0.03% 172
2024
Q1 		$1.31M Sell
2,432
-25
-1% -$13.7K 0.02% 269
2023
Q4 		$1.36M Buy
2,457
+692
+39% +$325K 0.02% 260
2023
Q3 		$772K Buy
1,765
+7
+0.4% +$3.49K 0.01% 320
2023
Q2 		$883K Sell
1,758
-21
-1% -$10.1K 0.01% 270
2023
Q1 		$890K Sell
1,779
-221
-11% -$106K 0.02% 268
2022
Q4 		$816K Buy
2,000
+187
+10% +$72.6K 0.01% 297
2022
Q3 		$591K Sell
1,813
-49
-3% -$18K 0.01% 304
2022
Q2 		$653K Buy
1,862
+155
+9% +$63.2K 0.01% 281
2022
Q1 		$934K Buy
1,707
+230
+16% +$121K 0.02% 198
2021
Q4 		$973K Sell
1,477
-175
-11% -$110K 0.02% 230
2021
Q3 		$1.03M Buy
1,652
+462
+39% +$310K 0.02% 242
2021
Q2 		$752K Sell
1,190
-365
-23% -$202K 0.02% 186
2021
Q1 		$761K Buy
1,555
+228
+17% +$114K 0.02% 308
2020
Q4 		$663K Sell
1,327
-2,787
-68% -$1.25M 0.02% 261
2020
Q3 		$1.62M Buy
4,114
+50
+1% +$18.5K 0.1% 99
2020
Q2 		$1.34M Sell
4,064
-3,283
-45% -$951K 0.09% 92
2020
Q1 		$1.78M Buy
7,347
+5,250
+250% +$1.37M 0.07% 137
2019
Q4 		$548K Buy
2,097
+67
+3% +$17.7K 0.04% 98
2019
Q3 		$552K Buy
+2,030
New +$565K 0.05% 81
2019
Q1 		– Sell
-423
Closed -$79K – 391
2018
Q4 		$79K Buy
+423
New +$86.7K 0.01% 129

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Wealthspire Advisors (New York)'s IDXX Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its Idexx Laboratories (IDXX) stake by 45% in Q2 2026, buying an estimated $867K and bringing the position to 4,941 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #373.

Wealthspire Advisors (New York) first reported a position in IDXX in Q4 2018 and has held it in 29 quarters since. The position peaked at $3.29M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Wealthspire Advisors (New York) held 4,941 shares of Idexx Laboratories worth $2.6M as of Q2 2026.
  • Wealthspire Advisors (New York) bought 1,545 Idexx Laboratories shares in Q2 2026, an estimated $867K.
  • Idexx Laboratories made up 0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #373 holding.
  • Wealthspire Advisors (New York) first reported a position in Idexx Laboratories in Q4 2018 and has held it in 29 quarters since.
  • Wealthspire Advisors (New York)'s Idexx Laboratories position peaked at $3.29M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.